0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Ariel Graff-Guerrero, MD, PhD; Tarek K. Rajji, MD; Benoit H. Mulsant, MD, MS; et al.
JAMA Psychiatry. 2015;72(9):927-934. doi:10.1001/jamapsychiatry.2015.0891.
Includes: Supplemental Content

Original Investigation | 
Joris Berwaerts, MD; Yanning Liu, MS; Srihari Gopal, MD, MHS; et al.
JAMA Psychiatry. 2015;72(8):830-839. doi:10.1001/jamapsychiatry.2015.0241.
Includes: CME, Supplemental Content

Original Investigation | 
Kenneth L. Subotnik, PhD; Laurie R. Casaus, MD; Joseph Ventura, PhD; et al.
JAMA Psychiatry. 2015;72(8):822-829. doi:10.1001/jamapsychiatry.2015.0270.
Includes: Supplemental Content

Original Investigation | 
David W. Oslin, MD; Shirley H. Leong, PhD; Kevin G. Lynch, PhD; et al.
JAMA Psychiatry. 2015;72(5):430-437. doi:10.1001/jamapsychiatry.2014.3053.
Includes: Supplemental Content

Original Investigation | 
Donovan T. Maust, MD, MS; Hyungjin Myra Kim, ScD; Lisa S. Seyfried, MD, MS; et al.
JAMA Psychiatry. 2015;72(5):438-445. doi:10.1001/jamapsychiatry.2014.3018.

Research Letter | 
Stacey C. Sigmon, PhD
JAMA Psychiatry. 2015;72(4):395-396. doi:10.1001/jamapsychiatry.2014.2421.

Research Letter | 
Lee M. Hampton, MD, MSc; Matthew Daubresse, MHS; Hsien-Yen Chang, PhD; et al.
JAMA Psychiatry. 2015;72(3):292-294. doi:10.1001/jamapsychiatry.2014.2412.

Original Investigation | 
Susan L. McElroy, MD; James I. Hudson, MD, ScD; James E. Mitchell, MD; et al.
JAMA Psychiatry. 2015;72(3):235-246. doi:10.1001/jamapsychiatry.2014.2162.

Original Investigation | 
Jesse R. Fann, MD, MPH; Charles H. Bombardier, PhD; J. Scott Richards, PhD; et al.
JAMA Psychiatry. 2015;72(3):247-258. doi:10.1001/jamapsychiatry.2014.2482.

Viewpoint | 
Yuhua Bao, PhD; Yan Tang, MS; Julie Donohue, PhD
JAMA Psychiatry. 2015;72(3):201-202. doi:10.1001/jamapsychiatry.2014.2186.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Viewpoint  | 
Evaluation of Flibanserin Science and Advocacy at the FDA
Walid F. Gellad, MD, MPH; Kathryn E. Flynn, PhD; G. Caleb Alexander, MD, MS
JAMA Oncology
From The JAMA Network  | 
Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy
Jennifer A. Lo, BA; David E. Fisher, MD, PhD; Keith T. Flaherty, MD
JAMA Pediatrics
Viewpoint  | 
Global Collaboration to Develop New and Existing Drugs for Neonates
Jonathan M. Davis, MD; Mark A. Turner, MB, PhD, MRCPCH
JAMA
The JAMA Forum  | 
A New Focus on Prescription Drug Spending
Gail Wilensky, PhD